Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 82,367 |
|
|||||
| News | - | ||||||
| Day High | 24.00 | Low High |
|||||
| Day Low | 19.59 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pharvaris NV | PHVS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.52 | 7.15% | 22.77 | 17:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 20.74 | 19.59 | 24.00 | 22.77 | 21.25 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,912 | 82,367 | $ 21.79 | $ 1,794,489 | - | 7.93 - 33.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:19 | formt | 260 | $ 22.77 | USD |
Pharvaris NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 931.17M | 40.82M | - | 0 | -100.88M | -2.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Pharvaris NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHVS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.19 | 24.20 | 17.57 | 19.94 | 75,363 | 1.58 | 7.46% |
| 1 Month | 23.20 | 25.19 | 17.57 | 21.19 | 78,620 | -0.43 | -1.85% |
| 3 Months | 29.81 | 33.00 | 17.57 | 25.17 | 91,935 | -7.04 | -23.62% |
| 6 Months | 18.32 | 33.00 | 15.00 | 25.07 | 120,203 | 4.45 | 24.29% |
| 1 Year | 8.97 | 33.00 | 7.93 | 22.89 | 81,932 | 13.80 | 153.85% |
| 3 Years | 26.08 | 33.00 | 1.77 | 12.61 | 191,004 | -3.31 | -12.69% |
| 5 Years | 25.00 | 42.86 | 1.77 | 13.46 | 186,880 | -2.23 | -8.92% |
Pharvaris NV Description
| Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. |
